News | Clinical Decision Support | July 18, 2018

May decrease use of head CT imaging in low-risk pediatric populations

CT Decision Instrument Reliably Guides Pediatric Blunt Trauma imaging Decisions

This is a four-site prospective observational cohort. Image courtesy of Kirsty Challen, B.Sc., MBCHB, MRES, Ph.D., Lancashire Teaching Hospitals, United Kingdom.


July 18, 2018 — A new study finds The Pediatric NEXUS Head Computed Tomography (CT) Decision Instrument (DI) reliably identifies blunt trauma patients who require head CT imaging, and could significantly reduce the use of CT imaging. The findings of the study are published in the July issue of Academic Emergency Medicine, a journal of the Society for Academic Emergency Medicine (SAEM).

The lead author is Malkeet Gupta, M.D., MS, assistant clinical professor in the Department of Emergency Medicine at the University of California Los Angeles (UCLA).

The study by Gupta et al, validates the NEXUS Head Computed Tomography Decision Instrument in pediatric patients and provides clinicians with a highly sensitive tool to guide selective imaging decisions in blunt head injury patients. Unlike other decision instruments, the decision instrument asks providers to use clinical judgment to identify low-risk patients who need no imaging and then to apply the decision instrument to further reduce the planned imaging. This "judgment first, decision instrument second" approach may decrease head CT utilization in low-risk pediatric populations by up to 34 percent.

The findings of the study are discussed with Gupta in the featured episode of SGEM Hop (Skeptics Guide to EM Hot Off the Press).

Joshua S. Broder, M.D., director of the Emergency Medicine Residency Program and vice-chief for education in the Division of Emergency Medicine at Duke University School of Medicine, commented on the study, "This study provides another tool in our armamentarium for assessing pediatric patients with traumatic head injury and has the potential to reduce CT utilization. Some elements of the decision instrument are poorly predictive; scalp hematoma alone, for example, does not indicate substantial risk of injury. Changes in nomenclature could help. For example, the term 'high-risk' may not accurately describe patients who fail one or more measures on the instrument, as the rate of significant head injury in this group was approximately 7 percent. 'Non-low risk' or 'intermediate risk' may more accurately describe some patients who might be safely observed without imaging."

For more information: www.onlinelibrary.wiley.com

Reference

Gupta M., Mower W.R., Rodriguez R.M., Hendey G.W. "Validation of the Pediatric NEXUS II Head Computed Tomography Decision Instrument for Selective Imaging of Pediatric Patients with Blunt Head Trauma." Academic Emergency Medicine, April 17, 2018. https://doi.org/10.1111/acem.13431

 


Related Content

News | Ultrasound Imaging

June 3, 2025 — In a collaborative study between the Departments of Radiology at the Children’s Hospital of Philadelphia ...

Time June 04, 2025
arrow
News | Lung Imaging

April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...

Time April 17, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | SPECT Imaging

Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging ...

Time February 05, 2025
arrow
News | Computed Tomography (CT)

Dec. 3, 2024 — During RSNA '24, GE HealthCare announced the 510(k) submission to the U.S. Food and Drug Administration ...

Time December 18, 2024
arrow
News | SPECT Imaging

Dec. 2, 2024 — GE HealthCare has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing ...

Time December 05, 2024
arrow
News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
Subscribe Now